General BPH
Total Payments
$38,786
Transactions
2
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $38,786 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $38,786 | 2 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Feasibility of catheter less Water Vapor Therapy Rezum for the treatment of Benign Prostatic Hyperplasia BPH | Boston Scientific Corporation | $38,786 | 0 |
Top Doctors Receiving Payments for General BPH
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | New York, NY | $38,786 | 2 |
Ad
Manufacturing Companies
- Boston Scientific Corporation $38,786
Product Information
- Type Device
- Total Payments $38,786
- Total Doctors 0
- Transactions 2
About General BPH
General BPH is a device associated with $38,786 in payments to 0 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is Boston Scientific Corporation.
Payment data is available from 2021 to 2021. In 2021, $38,786 was paid across 2 transactions to 0 doctors.
The most common payment nature for General BPH is "Unspecified" ($38,786, 100.0% of total).
General BPH is associated with 1 research study, including "Feasibility of catheter less Water Vapor Therapy Rezum for the treatment of Benign Prostatic Hyperplasia BPH" ($38,786).